Hojo, Y.; Kishi, S.; Mori, S.; Fujiwara-Tani, R.; Sasaki, T.; Fujii, K.; Nishiguchi, Y.; Nakashima, C.; Luo, Y.; Shinohara, H.;
et al. Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8. Int. J. Mol. Sci. 2022, 23, 4002.
https://doi.org/10.3390/ijms23074002
AMA Style
Hojo Y, Kishi S, Mori S, Fujiwara-Tani R, Sasaki T, Fujii K, Nishiguchi Y, Nakashima C, Luo Y, Shinohara H,
et al. Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8. International Journal of Molecular Sciences. 2022; 23(7):4002.
https://doi.org/10.3390/ijms23074002
Chicago/Turabian Style
Hojo, Yudai, Shingo Kishi, Shiori Mori, Rina Fujiwara-Tani, Takamitsu Sasaki, Kiyomu Fujii, Yukiko Nishiguchi, Chie Nakashima, Yi Luo, Hisashi Shinohara,
and et al. 2022. "Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8" International Journal of Molecular Sciences 23, no. 7: 4002.
https://doi.org/10.3390/ijms23074002
APA Style
Hojo, Y., Kishi, S., Mori, S., Fujiwara-Tani, R., Sasaki, T., Fujii, K., Nishiguchi, Y., Nakashima, C., Luo, Y., Shinohara, H., & Kuniyasu, H.
(2022). Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8. International Journal of Molecular Sciences, 23(7), 4002.
https://doi.org/10.3390/ijms23074002